Skip to main content
GWGovwatch
CongressBillsCommitteesPresidentMoneyPulseMisconductElectionsMap
Donate

Weekly accountability digest

One email a week with new votes, moving bills, and misconduct updates. No spam.

GW

Govwatch. Public data about Congress, in one place, in plain English.

Built with public data. Not affiliated with the U.S. government.

Explore

  • Officials
  • Legislation
  • Committees
  • Congress Pulse
  • Trending Topics
  • Bipartisan Leaderboard
  • Weekly Digest
  • Misconduct
  • Predictions

Learn

  • How Congress Works
  • How a Bill Becomes Law
  • Campaign Finance 101
  • Glossary

Tools

  • My Representatives
  • Compare Members
  • Bill Watchlist
  • Search
  • District Map
  • Follow the Money
  • Watch Live

Site

  • About
  • Contact
  • Corrections
  • Privacy Policy
  • Terms of Service

Data Sources

Congress.gov API v3
Bills, members, votesGovInfo API
Floor speeches, reports, bill textFederal Election Commission (FEC)
Campaign financeVoteView (UCLA)
Ideology scores (DW-NOMINATE)GovTrack.us
Misconduct data (CC0)U.S. Census Bureau
District demographics

Data Last Updated

Bills & Votes: 1 hour ago
Support This Project

This site is free. Donations help cover hosting, API fees, and keeping the data fresh.

All data is sourced from official government APIs and public records. This site is for informational purposes only.

© 2026 Govwatch

HR629Referred to Committee

Ending Chemical Abortions Act of 2025

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-01-22
Introduced
21
Cosponsors
HR
ⓘ
Type

Sponsor

Andrew Ogles
Andrew Ogles
Republican · TN · Representative
Votes with party: 91.9% (555 recorded votes)

Full profile: /officials/O000175

Source: Congress.gov · FEC

Cosponsors (21)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

21 cosponsors on record at Congress.gov. The named list is syncing into Govwatch and will appear here shortly — view on Congress.gov in the meantime.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the House Committee on the Judiciary.

2025-01-22

Source: Congress.gov

Committee Activity

Currently in

  • House Committee on the JudiciaryReferred To · 2025-01-22

Plain-English Summary

This legislation would restrict access to mifepristone, a medication used in medication abortion, by limiting how it can be prescribed and distributed. The bill would affect women seeking abortion services, healthcare providers who offer medication abortion, and pharmaceutical companies that manufacture or distribute the drug. The measure has been referred to the House Judiciary Committee for consideration.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Crime and Law Enforcement
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.

  • HR9562Anchors Away Act
    Referred to Committee · 2026-06-30
  • HR9479Remigration Act
    Referred to Committee · 2026-06-25
  • HR9443Saving FACE Act of 2026
    Referred to Committee · 2026-06-24
  • HR9156Tiananmen Square Memorial Act of 2026
    Referred to Committee · 2026-06-04